- Reaction score
- 2,634
Big news!
http://globenewswire.com/news-relea...r-Potential-Novel-Treatment-of-Hair-Loss.html
AWESOME
Perhaps we could get our hands on the stuff via black market before the clinical trials need to be finished?
http://globenewswire.com/news-relea...r-Potential-Novel-Treatment-of-Hair-Loss.html
KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that it has entered into separate license agreements with Actelion Pharmaceuticals Ltd. and the University of Pennsylvania for a novel approach for the treatment of hair loss, which together could enable KYTHERA to bring a new treatment to the very large and still highly unsatisfied hair loss market.
AWESOME
These observations are potentially the most innovative new thinking in hair loss over the last two decades (Think Propecia). Setipriprant is believed to directly affect this hair loss pathway, and our own preclinical and in vitro human hair models confirmed this effect. It is a well-characterized molecule with a large safety database and we believe we can quicklyinitiate a development program to study it in hair loss. Putting these two pieces of the puzzle together is ideal and represents an example of our approach to scientifically sound and efficient drug development.
"... Actelion will be eligible to receive up to $27 million in potential development and regulatory milestones, as well as royalties on sales if setipiprant is successfully commercialized.."
Perhaps we could get our hands on the stuff via black market before the clinical trials need to be finished?